6.195
price up icon8.12%   0.465
after-market アフターアワーズ: 6.17 -0.025 -0.40%
loading
前日終値:
$5.73
開ける:
$5.85
24時間の取引高:
4.67M
Relative Volume:
1.42
時価総額:
$396.69M
収益:
$20.65M
当期純損益:
$-192.65M
株価収益率:
-2.3919
EPS:
-2.59
ネットキャッシュフロー:
$-134.39M
1週間 パフォーマンス:
+39.21%
1か月 パフォーマンス:
+42.09%
6か月 パフォーマンス:
-4.25%
1年 パフォーマンス:
+17.33%
1日の値動き範囲:
Value
$5.772
$6.58
1週間の範囲:
Value
$4.50
$6.58
52週間の値動き範囲:
Value
$2.8647
$9.305

Verve Therapeutics Inc Stock (VERV) Company Profile

Name
名前
Verve Therapeutics Inc
Name
セクター
Healthcare (1170)
Name
電話
(978) 501-3026
Name
住所
201 BROOKLINE AVENUE, BOSTON
Name
職員
274
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
VERV's Discussions on Twitter

VERV を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
VERV
Verve Therapeutics Inc
6.195 396.69M 20.65M -192.65M -134.39M -2.59
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Verve Therapeutics Inc Stock (VERV) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-15 アップグレード Cantor Fitzgerald Neutral → Overweight
2024-04-08 開始されました H.C. Wainwright Buy
2023-04-13 開始されました Canaccord Genuity Buy
2023-02-01 開始されました Cantor Fitzgerald Neutral
2022-12-15 開始されました Goldman Sell
2022-10-06 開始されました Credit Suisse Neutral
2022-08-25 アップグレード Stifel Hold → Buy
2022-06-17 開始されました BMO Capital Markets Outperform
2022-02-18 開始されました RBC Capital Mkts Outperform
2021-09-24 開始されました Stifel Hold
2021-07-12 開始されました Guggenheim Buy
2021-07-12 開始されました JP Morgan Neutral
2021-07-12 開始されました Jefferies Buy
2021-07-12 開始されました William Blair Outperform
すべてを表示

Verve Therapeutics Inc (VERV) 最新ニュース

pulisher
Jun 06, 2025

Lost Money on Verve Therapeutics, Inc.(VERV)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 06, 2025

Transcript : Verve Therapeutics, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 09 - marketscreener.com

Jun 06, 2025
pulisher
Jun 06, 2025

Verve Therapeutics (VERV) Just Reclaimed the 200-Day Moving Average - Yahoo Finance

Jun 06, 2025
pulisher
Jun 05, 2025

Wall Street Analysts See a 367.86% Upside in Verve Therapeutics (VERV): Can the Stock Really Move This High? - Yahoo Finance

Jun 05, 2025
pulisher
Jun 04, 2025

BNP Paribas Financial Markets Purchases Shares of 8,876 Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Verve Therapeutics, Inc. (NASDAQ:VERV) Shares Acquired by ProShare Advisors LLC - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

Verve Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Verve Therapeutics Grants Equity Awards to New Employees as Part of Inducement Stock Incentive Plan - Nasdaq

Jun 02, 2025
pulisher
Jun 02, 2025

Latest Employee Stock Grants: Verve Therapeutics Issues 87,000 Shares Worth of Equity Awards - Stock Titan

Jun 02, 2025
pulisher
Jun 01, 2025

Bank of America Corp DE Reduces Position in Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

Jun 01, 2025
pulisher
Jun 01, 2025

Verve Therapeutics, Inc. (NASDAQ:VERV) Shares Acquired by Ameriprise Financial Inc. - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Verve Therapeutics, Inc. (NASDAQ:VERV) Shares Purchased by Deutsche Bank AG - Defense World

May 31, 2025
pulisher
May 30, 2025

Nuveen Asset Management LLC Sells 355,953 Shares of Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

May 30, 2025
pulisher
May 29, 2025

37,984 Shares in Verve Therapeutics, Inc. (NASDAQ:VERV) Acquired by D. E. Shaw & Co. Inc. - Defense World

May 29, 2025
pulisher
May 29, 2025

Verve Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationVERV - ACCESS Newswire

May 29, 2025
pulisher
May 28, 2025

Canaccord Genuity Reaffirms Their Buy Rating on Verve Therapeutics (VERV) - The Globe and Mail

May 28, 2025
pulisher
May 28, 2025

Verve Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

Verve Therapeutics, Inc. (NASDAQ:VERV) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely - simplywall.st

May 28, 2025
pulisher
May 27, 2025

Verve Therapeutics, Inc. (NASDAQ:VERV) Shares Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World

May 27, 2025
pulisher
May 25, 2025

Verve Therapeutics (NASDAQ:VERV) Upgraded at Wall Street Zen - Defense World

May 25, 2025
pulisher
May 23, 2025

Northern Trust Corp Raises Holdings in Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

May 23, 2025
pulisher
May 22, 2025

Transcript : Verve Therapeutics, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-21-2025 03 - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Analysts Offer Predictions for VERV FY2026 Earnings - Defense World

May 22, 2025
pulisher
May 21, 2025

3 Top Genomics Stocks to Add to Your Portfolio in 2025 - Yahoo Finance

May 21, 2025
pulisher
May 20, 2025

Verve Therapeutics Leads The Charge With 2 Other Promising Penny Stocks - simplywall.st

May 20, 2025
pulisher
May 19, 2025

Bio/Pharmaceutical Outsourcing Report, March 2025 Edition - GlobeNewswire Inc.

May 19, 2025
pulisher
May 19, 2025

News Flash: Analysts Just Made An Incredible Upgrade To Their Verve Therapeutics, Inc. (NASDAQ:VERV) Forecasts - simplywall.st

May 19, 2025
pulisher
May 19, 2025

Analyst Forecasts For Verve Therapeutics, Inc. (NASDAQ:VERV) Are Surging Higher - Yahoo Finance

May 19, 2025
pulisher
May 19, 2025

Cantor Fitzgerald Issues Positive Outlook for VERV Earnings - Defense World

May 19, 2025
pulisher
May 18, 2025

Price T Rowe Associates Inc. MD Lowers Position in Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

May 18, 2025
pulisher
May 17, 2025

Brokerages Set Verve Therapeutics, Inc. (NASDAQ:VERV) PT at $25.75 - Defense World

May 17, 2025
pulisher
May 16, 2025

Analysts Offer Insights on Healthcare Companies: Verve Therapeutics (VERV), Nkarta (NKTX) and Kamada (KMDA) - The Globe and Mail

May 16, 2025
pulisher
May 15, 2025

Dimensional Fund Advisors LP Raises Holdings in Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

May 15, 2025
pulisher
May 15, 2025

Verve Therapeutics: Q1 Earnings Snapshot - CT Insider

May 15, 2025
pulisher
May 15, 2025

Verve Therapeutics Reports Q1 2025 Progress and Financials - TipRanks

May 15, 2025
pulisher
May 14, 2025

Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2025 Financial Results - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Verve Therapeutics (VERV) Beats Q1 EPS Estimates, Reports Signif - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

Verve Therapeutics (VERV) Exceeds Revenue Estimates and Advances - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Verve Therapeutics, Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 14, 2025

Verve Therapeutics (VERV) Exceeds Revenue Estimates and Advances Clinical Trials | VERV Stock News - GuruFocus

May 14, 2025
pulisher
May 12, 2025

Verve Therapeutics (VERV) Projected to Post Quarterly Earnings on Wednesday - Defense World

May 12, 2025
pulisher
May 11, 2025

Stifel Financial Corp Purchases 9,736 Shares of Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

May 11, 2025
pulisher
May 11, 2025

Tower Research Capital LLC TRC Lowers Stock Holdings in Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

May 11, 2025
pulisher
May 10, 2025

1 Beaten-Down Stock That Could Skyrocket By 321%, According to Wall Street - AOL.com

May 10, 2025
pulisher
May 08, 2025

Verve Therapeutics, Inc. (VERV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

May 08, 2025

Verve Therapeutics Inc (VERV) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
大文字化:     |  ボリューム (24 時間):